Halozyme Therapeutics (HALO) Income towards Parent Company (2010 - 2026)
Halozyme Therapeutics (HALO) posted Income towards Parent Company of $229.91 million for Q2 2026, up 39.2% from $165.16 million a year earlier and up 53.2% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Income towards Parent Company (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income towards Parent Company at Halozyme Therapeutics was $413.6 million, down 25.8% year-over-year; for FY2025, it came in at $316.89 million, down 28.6% from FY2024.
- Annual Income towards Parent Company shows a five-year compound annual growth rate of 19.7% (FY2020 to FY2025).
- In prior years, Halozyme Therapeutics' Income towards Parent Company was $444.09 million in FY2024 (+57.7%), $281.59 million in FY2023 (+39.3%), $202.13 million in FY2022 (-49.8%) and $402.71 million in FY2021 (+212.0%).
- The Q2 2026 figure stands as the highest quarterly Income towards Parent Company in data going back to Q2 2010.
- The strongest year-over-year quarter for Income towards Parent Company in the past five years was Q3 2021, with growth of 498.2%; the weakest was Q2 2022, with a decline of 75.2%.
- According to Business Quant data, Income towards Parent Company for the three prior quarters was $150.05 million (Q1 2026), -$141.59 million (Q4 2025) and $175.23 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Halozyme Therapeutics | 12.53 Bn | 11.13 Bn | 401.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 229.91 Mn |
| Mar 31, 2026 | 150.05 Mn |
| Dec 31, 2025 | -141.59 Mn |
| Sep 30, 2025 | 175.23 Mn |
| Jun 30, 2025 | 165.16 Mn |
| Mar 31, 2025 | 118.10 Mn |
| Dec 31, 2024 | 137.01 Mn |
| Sep 30, 2024 | 137.01 Mn |
| Jun 30, 2024 | 93.25 Mn |
| Mar 31, 2024 | 76.82 Mn |
| Dec 31, 2023 | 85.39 Mn |
| Sep 30, 2023 | 81.84 Mn |
| Jun 30, 2023 | 74.75 Mn |
| Mar 31, 2023 | 39.62 Mn |
| Dec 31, 2022 | 57.70 Mn |
| Sep 30, 2022 | 61.63 Mn |
| Jun 30, 2022 | 22.69 Mn |
| Mar 31, 2022 | 60.11 Mn |
| Dec 31, 2021 | 66.77 Mn |
| Sep 30, 2021 | 216.59 Mn |
API Access
Halozyme Therapeutics Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();